
BioRealm is a genomics, statistics, and information technology company with nearly two decades of experience solving research challenges for clients. They offer a comprehensive suite of services including bioinformatics, data management, predictive modeling, statistical genetics, and next-generation sequencing analysis. Their flagship product, the Smokescreen® Genotyping Array, is specifically designed for addiction research, offering extensive content related to addiction, nicotine, and tobacco. BioRealm emphasizes reproducible, transparent, and extensible research, adhering to HIPAA-compliant standards for data security. They leverage a transdisciplinary team of experts and cutting-edge methods to ensure project success, delivering high-quality results on time and within budget. Their expertise spans various research areas such as cancer, cardiovascular diseases, and translational research, utilizing both internal and cloud-based computing environments.

BioRealm is a genomics, statistics, and information technology company with nearly two decades of experience solving research challenges for clients. They offer a comprehensive suite of services including bioinformatics, data management, predictive modeling, statistical genetics, and next-generation sequencing analysis. Their flagship product, the Smokescreen® Genotyping Array, is specifically designed for addiction research, offering extensive content related to addiction, nicotine, and tobacco. BioRealm emphasizes reproducible, transparent, and extensible research, adhering to HIPAA-compliant standards for data security. They leverage a transdisciplinary team of experts and cutting-edge methods to ensure project success, delivering high-quality results on time and within budget. Their expertise spans various research areas such as cancer, cardiovascular diseases, and translational research, utilizing both internal and cloud-based computing environments.